Physician

Alexander V. Mezentsev, PA-C

According to 2025 Medicare claims, Alexander Mezentsev, PA-C (NPI: 1780988766) practices physician assistant in the Williamsport, PA market, with the plurality of this provider's patient population coming from Lycoming, PA. This provider's primary affiliated billing organization is GEISINGER-HM JOINT VENTURE LLC (NPI: 1952076119; TIN: 831871064) and primary practice location at 17756-7568. Mezentsev is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Mezentsev's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 228 traditional Medicare patients, billed 1,363 HCPCS/CPT codes, and received $30,347 in Medicare payments. The top billing code was 90662 (Influenza vaccine split virus, preservative free). Part D data shows 9,323 prescription claims across 805 beneficiaries totaling $819,072 in drug costs, led by Eliquis (Apixaban). DME data shows 33 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $410,400 to $819,072. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $21,346 and ending at $17,737.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	184	418	$19,436
2016	237	627	$28,663
2017	336	1,051	$36,437
2018	312	1,013	$32,135
2019	281	871	$36,619
2020	297	1,425	$35,690
2021	277	701	$29,880
2022	257	601	$32,371
2023	240	563	$26,662
2024	228	1,363	$30,347

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	650	7,822	$410,400
2016	677	8,373	$413,457
2017	944	13,300	$648,202
2018	1,015	16,170	$874,808
2019	829	11,631	$745,843
2020	844	10,144	$793,397
2021	753	8,707	$685,715
2022	649	7,924	$705,727
2023	725	8,066	$725,854
2024	805	9,323	$819,072

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	28	106	$16,793
2016	17	150	$14,987
2017	25	184	$13,244
2018	41	212	$13,131
2019	19	238	$10,782
2020	13	158	$10,891
2021	N/R	105	$7,499
2022	N/R	110	$14,735
2023	N/R	78	$15,150
2024	N/R	33	$10,273

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90662	Influenza vaccine split virus, preservative free	25	26	$81
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	94	107	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	167	283	$47
G0008	Administration of influenza virus vaccine	35	36	$31
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	209	351	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	109	6,710	$123,581
Jardiance	Empagliflozin	87	5,580	$105,844
Ozempic	Semaglutide	78	2,618	$77,781
Trulicity	Dulaglutide	35	1,092	$35,956
Xarelto	Rivaroxaban	31	1,790	$31,223

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	33	$10,273

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Alexander V. Mezentsev, PA-C?

Tedicare shows public-source Medicare data for Alexander V. Mezentsev, PA-C (NPI 1780988766), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander V. Mezentsev, PA-C have ACO affiliation data?

Alexander V. Mezentsev, PA-C is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Alexander V. Mezentsev, PA-C?

Alexander V. Mezentsev, PA-C is linked to GEISINGER-HM JOINT VENTURE LLC (billing NPI 1952076119) in the available physician profile data.

Does Alexander V. Mezentsev, PA-C have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.